- ARAB NEWS
- 24 Apr 2024
Since 1975
Arab News Japan
More than 3,000 companies from 70 countries are participating in the 2023 edition of Arab Health, which is taking place at the Dubai World Trade Center, the United Arab Emirates, from Jan. 30 to Feb. 2.
According to its organizers, Informa Markets, the event, which was first launched in 1975, is being held under the theme “Innovation and Sustainability in Healthcare” and showcases the growth opportunities present in the healthcare sector in the MENA region.
The exhibition features nine product sectors showcasing the latest technology and innovations in disposables, orthopedics, health care and general services, imaging, medical devices, IT, wellness and prevention, and infrastructure and assets.
It also offers conferences on internal medicine, pediatrics, and anesthesia and pain management will be new additions in 2023.
The Japan pavilion at Arab Health organized by JETRO. (ANJP Photo)Twenty one Japanese companies from the healthcare industry joined the Japan pavilion at Arab Health under the slogan “Japanese Quality” to show their increasing advancements in the sector. Eighteen of these companies operated under the Japan Pavilion organized by JETRO, while the other three were Shizuoka based companies that were presented as a group.
Miyazaki Anastasia, from the overseas market development division at JETRO, told Arab News Japan that this is the twelfth time that Japanese companies have participated in Arab Health and that the number of companies present at the exhibition this year had significantly increased in comparison to the previous year, where only six companies had participated. She also said that the Japan Pavilion had witnessed a huge demand in the products being offered within the course of the event, and that it has gotten the largest number of deals per companies present, amounting to approximately 300 deals having been negotiated over the four days.
One of the companies, Medmain, is a Japanese MedTech startup that develops and provides pathological AI analysis solution entitled “PidPort” that enables the presentation of highly accurate and rapidly analyzed results by pathology AI that is developed by deep learning. Such technology aims to revolutionize the medical imaging by enabling experts to access results remotely, which is in line with company’s mission “to create a world where medical services can be accessed with technology anywhere, anytime.”
From the Shizuoka-based companies present, ADD Corporation, based in Numazu City, offers a cryotherapy tub, which surrounds the body in a mist as cold as -120°C allowing a single person to sit inside and immerse in a three-minute cold bath.
ADD’s Cryotherapy tub at Arab Health, the Dubai World Trade Center, UAE. (ANJP Photo)Cryotherapy is a treatment that has been used for decades on athletes to aid recovery and in medicine. The tub introduces a modern approach to the treatment, made with high Japanese quality, and allows the person using it to be treated with the swirling cold mist.
The physiological reactions to the cryotherapy application are favorable as they stimulate blood circulation. The extreme cold facilitates the contraction of blood vessels, prompting the nervous system to send a signal to the body ordering it to raise the skin temperature by increasing blood flow, which results in enhanced blood circulation. It is thought to help inflammation and tissue damage, and to help athletes, business people as well as the elderly recover faster.
TAUNS TAUNS stand at Arab Health, the Dubai World Trade Center, UAE. (ANJP Photo)Another Japanese company, TAUNS Laboratories, Inc. is one of the major manufacturers of rapid diagnostic antigen test kits for infectious diseases as well as a range of high-quality consumable medical products that are manufactured in Shizuoka, Japan.
Several products were presented at the Arab Health Exhibition, one of the most unique testing kits available is the SARS-CoV-2/Flue test, which is a rapid test that detects the SARS-CoV-2/Flu A/B virus antigen in 15 minutes. According to a TAUNS representative, the company is currently working to further improve the product through reducing the time needed for the reduce the time needed for the determination of results. This test proves important today due to the uncertainty stemming from the similarity between the symptoms of influenza and that of COVID-19.
The second kit is one that is used to quickly detect the presence of the “MPB64” protein produced by the Mycobacterium tuberculosis complex, which consists of causative agents of both human and animal tuberculosis in 15 minutes.
TAUNS also has other rapid test products that detect the presence of of Influenza A and B virus antigens, RS virus antigens, and adenovirus antigens.
Shams Qamar, acting as one of the representatives for TAUNS and Shizuoka Prefecture companies, said that while TAUNS products are used by medical institutions all over Japan, as well as other countries across the world from the EU to the US, the company has its sights set on expanding into the Middle East, and the UAE specifically, as they consider it a region that is “booming.”
“The Shizuoka Prefecture companies can introduce and supply good Japanese products to Arabian countries,” Shams Qamar said.
The exhibition allows companies to display their products and exchange their experiences while revealing the latest developments in the field of medicine, health and medical technology. The participation of Japanese companies specifically highlights the special relations between the UAE and Japan and their enthusiasm on working together to exchange expertise. It also shows how a country that is a forerunner of a future aging world could benefit those that are to follow by demonstrating the health services and products that have been developed.
